Elevai Labs, Common Stock Market Value
| ELAB Stock | 1.99 0.11 5.24% |
| Symbol | Elevai |
Elevai Labs, Common Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (88.92) | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.913 | Return On Assets (0.89) | Return On Equity (3.51) |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Elevai Labs, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Elevai Labs,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Elevai Labs,.
| 09/04/2024 |
| 12/03/2024 |
If you would invest 0.00 in Elevai Labs, on September 4, 2024 and sell it all today you would earn a total of 0.00 from holding Elevai Labs, Common or generate 0.0% return on investment in Elevai Labs, over 90 days. Elevai Labs, is related to or competes with Baxter International, West Pharmaceutical, ResMed, Cooper Companies,, ICU Medical, AngioDynamics, and AptarGroup. Elevai Labs, is entity of United States. It is traded as Stock on NASDAQ exchange. More
Elevai Labs, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Elevai Labs,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Elevai Labs, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 106.14 | |||
| Value At Risk | (31.03) | |||
| Potential Upside | 12.9 |
Elevai Labs, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elevai Labs,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Elevai Labs,'s standard deviation. In reality, there are many statistical measures that can use Elevai Labs, historical prices to predict the future Elevai Labs,'s volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (3.02) | |||
| Total Risk Alpha | (5.65) | |||
| Treynor Ratio | 1.25 |
Elevai Labs, Common Backtested Returns
Elevai Labs, Common secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24% return per unit of risk over the last 3 months. Elevai Labs, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Elevai Labs,'s Variance of 243.17, mean deviation of 9.41, and Standard Deviation of 15.59 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -2.67, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Elevai Labs, are expected to decrease by larger amounts. On the other hand, during market turmoil, Elevai Labs, is expected to outperform it. At this point, Elevai Labs, Common has a negative expected return of -3.74%. Please make sure to confirm Elevai Labs,'s standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if Elevai Labs, Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.76 |
Good predictability
Elevai Labs, Common has good predictability. Overlapping area represents the amount of predictability between Elevai Labs, time series from 4th of September 2024 to 19th of October 2024 and 19th of October 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Elevai Labs, Common price movement. The serial correlation of 0.76 indicates that around 76.0% of current Elevai Labs, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 49.59 |
Elevai Labs, Common lagged returns against current returns
Autocorrelation, which is Elevai Labs, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Elevai Labs,'s stock expected returns. We can calculate the autocorrelation of Elevai Labs, returns to help us make a trade decision. For example, suppose you find that Elevai Labs, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Elevai Labs, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Elevai Labs, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Elevai Labs, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Elevai Labs, stock over time.
Current vs Lagged Prices |
| Timeline |
Elevai Labs, Lagged Returns
When evaluating Elevai Labs,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Elevai Labs, stock have on its future price. Elevai Labs, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Elevai Labs, autocorrelation shows the relationship between Elevai Labs, stock current value and its past values and can show if there is a momentum factor associated with investing in Elevai Labs, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Elevai Labs, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs, Common Stock:Check out Elevai Labs, Correlation, Elevai Labs, Volatility and Elevai Labs, Alpha and Beta module to complement your research on Elevai Labs,. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Elevai Labs, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.